Manuela Callari, PhD, is an award-winning freelance science and medical journalist. She has a PhD in medical science, a bachelor’s and a master’s degree in material science, and a post-graduate degree in science communication.

Associate Professor Peta Stapleton is a registered clinical and health Psychologist who embraces evidence-based and innovative techniques. Peta is a world-leading researcher in Emotional Freedom Techniques (‘Tapping’) and has been awarded many achievements including the 2014 Harvey Baker Research Award for meticulous research (Association of Comprehensive Energy Psychology, USA), the 2015 Global Weight Management Congress Industry Professional Award of Excellence, the 2015 Gold Coast Women in Business Women in Change Award and the 2018 Innovation and Technology Award Winner. In 2016 Peta was awarded the Most Contribution to the Field (energy psychology) and was named the 2019 Research Supervisor of the Year at Bond University. In 2019 Peta was also named Psychologist of the Year (by the Australian Allied Health Awards).

Peta is a featured EFT Tapping presenter on Gaia, SBS Warner Brother Myth vs Medicine research expert, yearly presenter on the international Tapping World Summit, and is featured on Prime USA (Chasing The Present Film). Peta 2018 TEDx Is Therapy Facing a Revolution is now hosted on the official TED website. Peta is one of two Bond University Gold Coast Tourism and Business Event Ambassadors, bringing conferences and events to the Gold Coast.

Lakshini has over 10 years of experience in healthcare communications and medical education. She is passionate about transforming complex science into compelling stories that drive better treatment outcomes. Lakshini has successfully supported the delivery of strategic, scientific, and commercial programmes across the communications spectrum. A true scientist at heart, Lakshini holds a PhD in Neuroscience from the University of Auckland.

Lindy Willmott is a Professor of Law at Queensland University of Technology and a member of the Australian Centre for Health Law Research at the University. She researches in the area of the law that regulates the end of life, and particularly voluntary assisted dying, and publishes extensively in this field. Professor Willmott is the co-author of many text books in a range of areas and the website ‘End of Life Law in Australia’. She also is an editor of the text Health Law in Australia.

Ben White is Professor of End-of-Life Law and Regulation and an Australian Research Council Future Fellow (Professorial level, 2020-2024) in the Australian Centre for Health Law Research at the Faculty of Business & Law, Queensland University of Technology. His area of research focus is end-of-life decision-making with a particular focus on voluntary assisted dying.

Ben graduated with first class Honours and a University Medal in Law from the Queensland University of Technology. He was awarded a Rhodes Scholarship to complete a DPhil at Oxford University, where his doctoral thesis investigated the role that consultation plays in the law reform process. Before joining the Law School, he worked as an Associate at the Supreme Court of Queensland and at Legal Aid Queensland. Between 2005 and 2007, Ben was appointed as the full-time Commissioner of the Queensland Law Reform Commission where he had carriage of the Guardianship Review on behalf of the Commission. He also served as a part-time Commissioner between 2007 and 2010.

Ben was a foundation Director of the Australian Centre for Health Law Research for six years (2013-2018). He still co-leads the End-of-Life Research Program within the Centre. He has published over 150 book chapters and journal articles in the area of health law, with a particular focus on end-of-life decision-making. His work is interdisciplinary with publications in law, medicine, bioethics, social science and psychology journals as well as those that have an interdisciplinary focus. He is an editor of the leading text Health Law in Australia (2018, 3rd ed, Thomson) and International Perspectives on End-of-Life Law Reform: Politics, Persuasion and Persistence (2021, Cambridge University Press).

Ben has been part of interdisciplinary teams that have been awarded $45 million in the field of end-of-life decision-making, including from the Australian Research Council, the National Health and Medical Research Council and Commonwealth and State governments. His five Australian Research Council grants have examined different aspects of law, policy and practice at the end of life. Key topics investigated include: What role does law play in medical decision-making? To what extent do doctors know and follow the law? Why is medical treatment that is futile/non-beneficial provided to patients at the end of life? How many people make a will or engage in advance care planning and why? What does the community know about the law of end-of-life decision-making? Do patients and families know their rights and responsibilities when making end-of-life decisions?

Ben is currently undertaking a four-year full-time Australian Research Council Future Fellowship (2020-2024) that aims to develop a new and holistic approach to regulating voluntary assisted dying. This project will enhance end-of-life care in Australia through better regulation and will draw on Canadian and Belgian case studies. Ben is a Chief Investigator on a National Health and Medical Research Council project involving an intervention to address futile or non-beneficial treatment at the end of life. He has also been an Associate Investigator on two Centres of Research Excellence, one in End-of-Life Care and the other on Chronic Kidney Disease.

Ben is also currently developing funded training and research programs about end-of-life law. These programs include the legislatively-mandated training that health professionals must complete before being involved in voluntary assisted dying in Victoria, Western Australia and Queensland (funded by these State Governments). Another is a national program funded by the Commonwealth Department of Health to enhance health professionals’ knowledge of law at the end of life called End of Life Law for Clinicians. He also contributes to the Commonwealth Government-funded End of Life Directions for Aged Care project.

Ben’s research has had significant impact leading to changes in law, policy and practice. His work has been adopted by parliaments, courts and tribunals, and law reform commissions and has also influenced state and national end-of-life policy and prompted changes to clinical education in universities, hospitals and health departments. His research has also contributed to voluntary assisted dying law reform across Australia, and particularly in Queensland. His legal research is publicly available through the End of Life Law in Australia website (co-authored with Lindy Willmott and Penny Neller). This site aims to provide accessible information about law at the end of life for patients, families, health and legal practitioners, the media, policymakers and the broader community.

A list of Ben’s publications and other outputs is available here: http://eprints.qut.edu.au/view/person/White,_Ben.html.

Dinukshi graduated from the University of Sydney with a Bachelor of Medical Science in 2001 followed by a Bachelor of Dentistry in 2005 and in recent years has been working as a director and principal dentist. Dinukshi has a well- rounded skill set in most areas of dentistry and treatment planning and has a particular interest in the correlation of sleep disorders to dentistry.

Dinukshi will be responsible for managing and developing the association’s new certification for dental sleep medicine professionals, the Fellow of Dental Sleep Medicine program.

Deborah Lupton is a sociologist with a Master of Public Health and a doctorate in the sociology of public health. She is the author/co-author of 20 books and over 270 peer-reviewed journal articles and book chapters. Deborah leads the Vitalities Lab at UNSW Sydney and also leads the UNSW Node of the ARC Centre of Excellence for Automated Decision-Making and Society as well as its Health Focus Area and is co-leader of the People Program.

Deborah blogs on sociological issues at ‘This Sociological Life’ and tweets @DALupton. She is an elected Fellow of the Academy of Social Sciences in Australia and the Royal Society of New South Wales.

Ashley has a particular clinical interest in managing metabolic fatty liver disease, and has an appointment at Monash Health where he is involved in clinical trials and fatty liver disease research.
Ashley is proficient at managing a range of gastroenterological issues, including liver disease, inflammatory bowel disease, and irritable bowel syndrome.
He also performs upper and lower Gastrointestinal
Endoscopy (Gastroscopy and Colonoscopy), including polypectomy.

Ashley is passionate about helping people reach their best health potential and is happy to be to contacted by health practitioners to discuss patient needs.

I am an academic child and adolescent psychiatrist based at the University of Melbourne departments of paediatrics and psychiatry. My main research focus is on neurodevelopmental disorders in children and youth. I spent much of my career in Scotland at the University of Dundee moving to Australia in 2016. Throughout my career I have kept a strong clinical interest with a particular focus on implementing evidence based care into routine clinical practice.

Professor Adam Guastella is the Michael Crouch Chair in Child and Youth Mental Health. His position is based at both Sydney Children’s Hospital at Westmead and the Brain and Mind Centre, University of Sydney. His work aims to build collaborative partnerships between researchers, clinicians, and services to ensure that children and families receive the best available assessments and treatments to support well-being.

As part of this role, he is the co-lead of the Child-Neurodevelopment and Mental Health Team for the University of Sydney. This team aims to solve complex problems for children with neurodevelopmental dconditions and their families with a team of multi-disciplinary professors across the university.

Professor Guastella also has an established track record in human translational neuroscience. His primary interest is in using neuroscience to inform and develop novel treatments for young patients with mental health problems. This research has led him to study the neurobiology of social behaviour, its development in early life, and how this neurobiology relates to symptoms that cause distress and impairment. His research may also take the form of cognitive-experimental investigations and he has developed a number of mental health programs to support wellbeing for adults on the spectrum.

Farming cattle, sheep and poultry from an early age in Somerset, Philippe quickly developed an interest in native livestock. He obtained a Masters in Chemistry with First Class Honours from the University of Bath in 2014, and went on to carry out a PhD in Bath under the supervision of Professor Ian H. Williams, completing this in 2016. He is a Fellow of the Higher Education Academy and completed a Postgraduate Certificate in Learning and Teaching in Higher Education in 2018. He is now a Professor of Animal Science and Bioinformatics within the School of Animal, Rural and Environmental Science, and Professor of One Health Medical Technologies for Diagnosis, Prevention and Treatment at NTU as well as being appointed as Chief Scientific Officer at Willows Health under NHS Leicestershire. He has already received numerous international awards in recognition of his multidisciplinary approaches to analytical science: he was named by the prestigious Forbes Magazine in their 30under30 listing for Science and Healthcare in 2018, awarded the Royal Society of Chemistry Joseph Black Medal for his research and pedagogy in analytical chemistry in 2019, and was named as one of the top 118 young chemists in the world by IUPAC in their 2019 Periodic Table of Younger Chemists, being named as the element Krypton. The group employs the computational and practical techniques in studies of the metabolome, proteome and genome in humans and animals. Philippe’s research group were the first to carry out metabolomic analyses on low field, benchtop NMR spectrometers and his works remain the pioneering papers in this nascent field. Furthermore, he has gained funding from Cancer Research UK, the Engineering and Physical Sciences Research Council, The Science and Technologies Facilities Council, and the Royal Society to further develop his unique bimodal approach to low- and ultra-low-field NMR analysis combining optimised protocols with bespoke computational frameworks. He is the author of more than 50 articles, books, book chapters and conference proceedings, including editing the upcoming Royal Society of Chemistry text Computational Approaches in Analytical Chemistry and Bioanalysis. Philippe is appointed to the Farm Animal Genetic Resources Committee within the Department for Food, Environment and Rural Affairs in UK Government, and the Committee on the Toxicity of Chemicals in Food, Consumer Products and the Environment at Public Health England and the Food Standards Agency. He is a Fellow of the Royal Society of Biology, and a Fellow of the Linnean Society of London. He has delivered invited lectures internationally.

Dr Samuel White is a Senior Lecturer within the department of Animal, Equine and Veterinary Sciences at Nottingham Trent University. His research is wide-ranging covering applied immunology and genetics with a one health approach to identifying biomarkers, protein allergenicity, multi-omics and novel diagnostic/therapeutic approaches. Prior to joining NTU, Dr White ran his own laboratory and consultancy company, was an Associate Researcher at the University of Nottingham, worked as a UKAS Assessor and Quality Manager for North Somerset Council Laboratory. Samuel holds a BSc (Hons) from University of the West of England, an MSc from the Royal Agricultural University, and a PhD in Applied Immunology from the University of Gloucestershire. Research areas Dr White’s research spans a wide range of different clinical conditions, allergies and inflammatory diseases, but the overarching theme is the novel development of diagnostics, and advancing treatments. Ongoing/current research interests include: Multi-omics Microbial identification through next generation sequencing Whole genome sequencing (including variant identification) Microbiome profiling Protein expression Protein allergenicity Microarray development Lateral flow assay development Immunoglobulin isotype profiling Allergen-specific immunotherapy